December 16, 2019, Foster City, CA, Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced the...
The Wall Street Journal Reports on Expansion of Leadership Team at Pappas Capital
News | 07. 16. 2019
July 16, 2019 – The Wall Street Journal Reports on Expansion of Leadership Team at Pappas Capital
